Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

Elsevier launches PharmaPendium AI - a generative AI assistant for regulatory intelligence in drug development.

Sep 4, 2025, 09:23 AM by

MultiOmic Health Limited (“MOH”), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (“BIO4”), the Republic of Serbia's flagship biotechnology and life sciences hub, today announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications.

Sep 4, 2025, 01:00 AM by User Not Found

Bio-IT World| Researchers in Denmark report finding a potential new route for developing microbiome-based therapies by providing “a concrete example” of how specific bacterial proteins might be used in the treatment of chronic metabolic diseases. Specifically, they identified a common gut bacterium capable of producing hormone-like proteins measurably influencing weight, bone density, and blood sugar regulation in preclinical models.

Sep 3, 2025, 08:00 AM by

• New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior • End-to-end support from experimental design to data interpretation

Sep 3, 2025, 08:00 AM by

Sep 3, 2025, 08:00 AM by

Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) in Obesity.

Sep 3, 2025, 08:00 AM by

PhenoTips, based in Toronto, has developed a first-of-its-kind cloud-based software that streamlines and digitizes genomic health record management, saving clinicians time and supporting precision medicine initiatives. In June 2025, PhenoTips was one of 13 Ontario-based life sciences companies to receive the renewed Life Sciences Innovation Fund from the government of Ontario, through the Ontario Centre of Innovation (OCI).

Sep 3, 2025, 01:00 AM by User Not Found

Bio-IT World| A large segment of the population holds negative views towards psychedelics, even in therapeutic contexts. Up until a few years ago, those people included Kosuke Kato, Ph.D., assistant professor of medicine at Baylor College of Medicine. His perspective changed when he and Louise Hecker, Ph.D., then working at Emory University, began reading up on the experimental use of psilocybin in treating various psychiatric and age-related neurodegenerative diseases.

Sep 2, 2025, 01:00 AM by User Not Found

Bio-IT World | Researchers at the Icahn School of Medicine at Mount Sinai have published a machine learning model to predict penetrance of genetic variants—how likely the variants are to cause disease. The tool combines genomic and clinical phenotype data to evaluate penetrance at scale, offering refined, individualized disease risk estimates. The study was published last week in Science (DOI: 10.1126/science.adm7066).

Aug 28, 2025, 10:01 AM by

Aug 28, 2025, 10:01 AM by

• Qureight’s advanced AI 3D imaging platform to be used across clinical trial to evaluate anatomical lung changes in adult patients, including during patient enrolment • CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF

Aug 28, 2025, 10:01 AM by

Rousselot announces promising preclinical results from a study conducted by Cellbricks Therapeutics, a Berlin-based biotech startup and spin-off from the Technical University of Berlin. As a pioneer in 3D-bioprinting, Cellbricks successfully implanted 3D-bioprinted adipose tissue constructs into mice, with no signs of fibrosis or rejection observed after seven weeks.

Aug 28, 2025, 10:01 AM by

Aug 28, 2025, 10:01 AM by

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx

Aug 28, 2025, 01:00 AM by User Not Found

Bio-IT World| Ultima Genomics unveiled updates on the single-nucleotide variant (SNV) detection capabilities of its plus-minus sequencing (ppmSeq) technology, which were published at bioRxiv. The updates elaborate beyond the limits of currently available minimal residual disease assays.

Aug 27, 2025, 08:24 AM by

Huateng Pharma offers reliable cosmetic ingredients including Diethylamino Hydroxybenzoyl Hexyl Benzoate, Tetrahydrocurcumin, and Piroctone Olamine.

Aug 27, 2025, 01:00 AM by User Not Found

Bio-IT World| SetPoint Medical will advance commercialization of the SetPoint System, a first-of-its-kind neuroimmune modulation therapy for adults living with moderate-to-severe rheumatoid arthritis; Sava Technologies plan to accelerate regulatory approval and commercialization of its next-generation wearable; and more.